Patients who have asthma or who have children who are at risk of developing asthma may wonder what they can do to prevent or control the condition. Does nutrition play a role in helping or worsening asthma, and what can you tell your patients?
Large study of Hispanic adults shows association with risk for chronic obstructive pulmonary disease before age 50.
Individuals should continue to receive asthma care and take asthma medications during the pandemic.
Risk slightly higher after introduction of nationwide pneumococcal conjugate vaccine.
Patients with severe asthma with low baseline cytokine levels responded well to benralizumab therapy.
Greatest decrease seen for those previously working outside of the home and in those without ‘allergic-type’ inflammation
Asthma rates for boys decline with age but stay steady among girls; rates higher among Black versus non-Hispanic White children during preschool years
Patients who have severe eosinophilic asthma that is uncontrolled on omalizumab may be effectively switched to mepolizumab.
The 6-minute pegboard and ring test can be used as a valid and reliable test to evaluate functional arm exercise capacity in patients with well-controlled asthma.
Adolescent boys with a higher BMI, adenotonsillar hypertrophy, and sleep-disordered breathing have an increased risk for moderate to severe obstructive sleep apnea.
Investigators sought to better understand the immunologic mechanisms behind increased susceptibility to secondary respiratory infections.
In patients with refractory eosinophilic asthma, treatment with benralizumab is a cost-effective option to be used as add-on therapy.
The cumulative odds ratio for incident asthma in children was 4.28 per doubling of UFP exposure level across pregnancy.
The novel ORACLE scale (Oxford Asthma Attack Risk Scale) demonstrated potential to predict — and subsequently prevent — asthma attacks using biomarkers of type 2 airway inflammation.
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
The primary treatment goals of ABPA include controlling symptoms of asthma or cystic fibrosis, preventing and/or treating pulmonary exacerbation, decreasing pulmonary inflammation, and reducing the progression of pulmonary disease.
Patients with severe asthma who had high levels of fractional exhaled nitric oxide (FeNO) were more likely to have asthma exacerbations than those with low levels.
Asthma and chronic obstructive pulmonary disease (COPD) do not appear to increase the risk of mortality in patients with COVID-19.
Spirometry measurements obtained at home had poor agreement with results obtained in the clinic.
Although asthma and autoimmune disease are thought to have mutually exclusive pathogeneses, they both result from a dysregulated immune system.